Insider Transactions in Q1 2024 at Lyell Immunopharma, Inc. (LYEL)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2024
|
Matthew Lang Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Feb 09
2024
|
Gary K. Lee Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+43.15%
|
-
|
|
Feb 09
2024
|
Stephen J. Hill Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+44.98%
|
-
|
|
Feb 09
2024
|
Lynn Seely President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+50.0%
|
-
|
|
Feb 09
2024
|
Charles W. Newton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+45.08%
|
-
|